Search This Blog

Wednesday, November 6, 2019

Emergent Biosolutions EPS beats by $0.26, beats on revenue

Emergent Biosolutions (NYSE:EBS): Q3 Non-GAAP EPS of $1.21; GAAP EPS of $0.83 beats by $0.26.
Revenue of $311.8M (+79.6% Y/Y) beats by $22.64M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)